Bharat Biotech warns people about its cocaine vaccine

Bharat Biotech has issued some conditions regarding its vaccine. The name of the Covid-19 vaccine of Bharat Biotech is Covaxine. The company has uploaded a statement on its website, telling which people do not want to apply cocaine.

According to the statement, Bharat Biotech advised people not to apply covacine to those with allergy, fever, and bleeding disorders, people who take blood-thinning medicines, and people who take medicines for immunity.

In addition, pregnant women and those who breastfeed have also been prohibited from applying this vaccine. English newspaper ‘The Hindu’ has made this news the lead of the front page.

The company said in its statement, “Covicin can cause severe allergic reactions. It can cause problems in breathing, swelling of face or neck, rapid heartbeat, body rash, dizziness and weakness.”

Bharat Biotech has now released the factsheet, which informs the possible side effects of the cocaine vaccine.

According to The Hindu’s report, the clinical affixation rate of the cocaine vaccine has not been reported yet. The study of a clinical trial of phase three of the vaccine is still going on. The company has also said that applying the vaccine does not mean that diet is not to be followed to stop Covid-19.

According to a newspaper report, according to an order from the Ministry of Health, people cannot decide which vaccine they will get, although whether or not the vaccine is voluntary. A vigilant awareness campaign is being conducted by health experts and Indian Medical Association (IMA) for this.

The newspaper says that after applying the vaccine, 447 people have seen its side effects. Three of these people had to be hospitalized. In such a situation, the emphasis is being given to spread awareness about the vaccine.

A Health Ministry official from The Hindu has said that the process of vaccination involves taking complete information about the health of the person and monitoring it after applying the vaccine.

Also read: COVID vaccine: WHO warns of ‘catastrophic failure’